Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Audentes Therapeutics (BOLD) Earnings Date, Estimates & Call Transcripts

Audentes Therapeutics logo

Audentes Therapeutics Latest Earnings Summary

Upcoming
Earnings Date
Feb. 6Estimated
Actual EPS
(Nov. 7)
-$0.74 Beat By $0.02
Consensus EPS
(Nov. 7)
-$0.76

Audentes Therapeutics issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.74, which topped analysts' consensus estimates of -$0.76 by $0.02. With a trailing EPS of $0.00, Audentes Therapeutics' earnings are expected to grow next year, from ($3.85) to ($3.72) per share.

BOLD Upcoming Earnings

Audentes Therapeutics' next earnings date is estimated for Thursday, February 6, 2025, based off prior year's reporting schedules.

Get Audentes Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Audentes Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BOLD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BOLD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Audentes Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241-$0.77-$0.77-$0.77
Q3 20241-$0.76-$0.76-$0.76
Q4 20241-$0.69-$0.69-$0.69

Audentes Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/6/2025
(Estimated)
------- 
11/7/2024--$0.76-$0.74+$0.02-$0.74--
8/12/2024Q2 2024-$0.80-$0.77+$0.03-$0.77--
5/13/2024Q1 2024-$0.65-$12.27 -$11.62-$12.27--

Audentes Therapeutics Earnings - Frequently Asked Questions

Audentes Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates. Learn more on BOLD's earnings history.

In the previous quarter, Audentes Therapeutics (NASDAQ:BOLD) reported ($0.74) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.02. Learn more on analysts' earnings estimate vs. BOLD's actual earnings.

Audentes Therapeutics (NASDAQ:BOLD) has a recorded net income of -$49.43 million. BOLD has generated $0.00 earnings per share over the last four quarters.

Audentes Therapeutics's earnings are expected to grow from ($3.85) per share to ($3.72) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BOLD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners